NCCN Guidelines for Patients® | Follicular Lymphoma Grade 1-2

64 NCCN Guidelines for Patients ® : Follicular Lymphoma, Grade 1–2, 2017 Index Index biopsy 10, 14, 16, 20, 22, 38, 40–41, 45 blood tests 17–19, 22 cancer grade 12–13 chemoimmunotherapy 39, 42, 44–45 chemotherapy 18, 26–29, 32, 34, 37–45 clinical trial 33–43, 49 complementary and alternative medicine 34 complete blood count 17 comprehensive metabolic panel 17 computed tomography 16, 19–20, 22, 30, 38, 41, 44 consolidation treatment 36, 40 diagnosis 10–13 fertility 16, 21–22, 28, 32 immunohistochemistry 12 immunomodulators 25, 34 immunotherapy 24, 27, 34, 37 involved-site radiation therapy 30 lymphatic system 8–9, 14, 37, 39 lymphocyte 8, 14, 29 maintenance treatment 36, 40, 44 medical history 16–17 NCCN Member Institutions 63 NCCN Panel Members 62 Non-Hodgkin’s lymphoma 8–9 observation 37, 39–40, 44 pathology report 13, 52 pediatric type 12, 37, 44–45 physical exam 17 positron emission tomography/computed tomography 19–20, 22, 30, 38, 41, 44 radiation therapy 30–31, 34, 37–45 radioimmunotherapy 30–31 stem cell transplant 32, 34, 42, 44 steroids 28, 34 supportive care 29, 36, 38, 40–41 targeted therapy 25, 29, 34, 42

RkJQdWJsaXNoZXIy MTE3MTE1